Progress in the Fight Against Cancer

Progress in the Fight Against Cancer

05.31.12 | By Preet Bilinski

Unfortunately, today most of us know someone that has had to battle cancer. On the bright side, more and more people are winning that fight. We've come a long way since signs of cancer were found in the bones of mummies from ancient Egypt, to declaring war on cancer, to approving vaccines for cancer.

A deep commitment to patients and research is at the core of the significant progress made in fighting cancer that has led to declines in cancer deaths. According to the American Cancer Society, the cancer death rate fell 22% for men and 14% for women between 1990 and 2007, which translated to 898,000 fewer deaths from the disease in this period.

>> Read more about Medicines in Development for Cancer.

America's biopharmaceutical research companies are testing 981 medicines and vaccines to fight the many types of cancer affecting millions of patients worldwide, according to a report released today. These potential medicines, which are either in clinical trials or under review by the Food and Drug Administration, include 121 for lung cancer, 117 for lymphoma and 111 for breast cancer. Some examples of the new cutting-edge approaches researchers are working on include:

  • A medicine that interferes with the metabolism of pancreatic cancer cells by depriving them of the energy provided by glucose.
  • A medicine for acute myeloid leukemia (AML) that inhibits cancer cells with a mutation found in about a third of AML sufferers.
  • A therapy that uses nanotechnology to target the delivery of medicines to prostate cancer cells, potentially overcoming some limitations of existing treatments.

As patients continue their battle against cancer, our biopharmaceutical companies continue to work on additional treatments for tomorrow.

More On PhRMA — powered by PhRMApedia


Cost in Context